TY - JOUR
T1 - Israeli national policy for carbapenem-resistant enterobacteriaceae screening, carrier isolation and discontinuation of isolation
AU - Solter, Ester
AU - Adler, Amos
AU - Rubinovitch, Bina
AU - Temkin, Elizabeth
AU - Schwartz, David
AU - Ben-David, Debby
AU - Masarwa, Samira
AU - Carmeli, Yehuda
AU - Schwaber, Mitchell J.
N1 - Publisher Copyright:
© 2017 by The Society for Healthcare Epidemiology of America.
PY - 2018/1/1
Y1 - 2018/1/1
N2 - Since 2006, Israel has been confronting an outbreak of carbapenem-resistant Enterobacteriaceae (CRE), and in 2007 Israel implemented a national strategy to contain spread. The intervention was initially directed toward acute-care hospitals and later expanded to include an established reservoir of carriage in long-term-care hospitals. It included regular reporting of CRE cases to a central registry and daily oversight of management of the outbreak at the institutional level. Microbiological methodologies were standardized in clinical laboratories nationwide. Uniform requirements for carrier screening and isolation were established, and a protocol for discontinuation of carrier status was formulated. In response to the evolving epidemiology of CRE in Israel and the continued need for uniform guidelines for carrier detection and isolation, the Ministry of Health in 2016 issued a regulatory circular updating the requirements for CRE screening, laboratory diagnosis, molecular characterization, and carrier isolation, as well as reporting and discontinuation of isolation in healthcare institutions nationwide. The principal elements of the circular are contained herein.
AB - Since 2006, Israel has been confronting an outbreak of carbapenem-resistant Enterobacteriaceae (CRE), and in 2007 Israel implemented a national strategy to contain spread. The intervention was initially directed toward acute-care hospitals and later expanded to include an established reservoir of carriage in long-term-care hospitals. It included regular reporting of CRE cases to a central registry and daily oversight of management of the outbreak at the institutional level. Microbiological methodologies were standardized in clinical laboratories nationwide. Uniform requirements for carrier screening and isolation were established, and a protocol for discontinuation of carrier status was formulated. In response to the evolving epidemiology of CRE in Israel and the continued need for uniform guidelines for carrier detection and isolation, the Ministry of Health in 2016 issued a regulatory circular updating the requirements for CRE screening, laboratory diagnosis, molecular characterization, and carrier isolation, as well as reporting and discontinuation of isolation in healthcare institutions nationwide. The principal elements of the circular are contained herein.
UR - http://www.scopus.com/inward/record.url?scp=85041506111&partnerID=8YFLogxK
U2 - 10.1017/ice.2017.211
DO - 10.1017/ice.2017.211
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.systematicreview???
C2 - 29241475
AN - SCOPUS:85041506111
SN - 0899-823X
VL - 39
SP - 85
EP - 89
JO - Infection Control and Hospital Epidemiology
JF - Infection Control and Hospital Epidemiology
IS - 1
ER -